General

Showing 1681–1696 of 2270 results

Article: P3.17 Azacytidine prevents experimental sclerodermic chronic graft-versus-host disease
€3.03 Add to cart
Article: P3.19 Spurious Decrease In The Wbc Count Measured By The Wnr Channel Of Xn Haematology Analyzer (Sysmex) Could Be Associated With Metastatic Adenocarcinoma
€3.03 Add to cart
Article: P30 Severe pancytopenia as presenting feature in newly diagnosed multiple myeloma (NDMM): a rare presentation
€3.03 Add to cart
Article: P30 The identification of actionable genetic events driving disease progression and heterogeneity in peripheral T cell lymphoma, not otherwise specified
€3.03 Add to cart
Article: P30 VWF DEFICIENCY IS ASSOCIATED WITH RETICULOCYTOSIS AND INCREASED PARASITE ACCUMULATION IN EXPERIMENTAL MALARIA-ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME
€3.03 Add to cart
Article: P31 Approach of an IgM monoclonal gammopathy: clinical relevance of the MYD88 L265P mutation
€3.03 Add to cart
Article: P31 HLTV-1 associated adult T cell leukaemia-lymphoma (ATLL) presenting as cutaneous lymphoma: a case report
€3.03 Add to cart
Article: P32 Belgian registry of breast implant-associated anaplastic large cell lymphoma
€3.03 Add to cart
Article: P33 Use of Ibrutinib for Chronic Lymphocytic Leukemia (CLL) in Routine Clinical Practice: Results from the Belgian Ibrutinib Real-World Data (BiRD) Study
€3.03 Add to cart
Article: P34 A crépinette sign
€3.03 Add to cart
Article: P35 In-house developed 15-gene sequencing panel for acute myeloid leukemia and myelodysplasia allows robust detection of genetic defects including FLT3-ITD and CEBPA mutations
€3.03 Add to cart
Article: P35 PD-1 blockade in a patient with relapsed Hodgkin lymphoma post-allogeneic hematopoietic cell transplant: complete metabolic response without graft-versus-host-disease
€3.03 Add to cart
Article: P36 Can CLL-IPI at time of diagnosis predict who may never need treatment for B-CLL?
€3.03 Add to cart
Article: P36 Next generation sequencing in patients with therapy-related myeloid neoplasms
€3.03 Add to cart
Article: P37 CD123 expression on acute leukemia blasts, hematogones, and monocytes; used as Minimal Residual Disease Marker
€3.03 Add to cart
Article: P37 Comparison of Multigam® IV (5% vs. 10%) in hematological patients with secondary immunodeficiencies to evaluate infusion time, tolerability and satisfaction. A monocentric observational Belgian study
€3.03 Add to cart

Article: P3.17 Azacytidine prevents experimental sclerodermic chronic graft-versus-host disease

Article: P3.19 Spurious Decrease In The Wbc Count Measured By The Wnr Channel Of Xn Haematology Analyzer (Sysmex) Could Be Associated With Metastatic Adenocarcinoma

Article: P30 Severe pancytopenia as presenting feature in newly diagnosed multiple myeloma (NDMM): a rare presentation

Article: P30 The identification of actionable genetic events driving disease progression and heterogeneity in peripheral T cell lymphoma, not otherwise specified

Article: P30 VWF DEFICIENCY IS ASSOCIATED WITH RETICULOCYTOSIS AND INCREASED PARASITE ACCUMULATION IN EXPERIMENTAL MALARIA-ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME

Article: P31 Approach of an IgM monoclonal gammopathy: clinical relevance of the MYD88 L265P mutation

Article: P31 HLTV-1 associated adult T cell leukaemia-lymphoma (ATLL) presenting as cutaneous lymphoma: a case report

Article: P32 Belgian registry of breast implant-associated anaplastic large cell lymphoma

Article: P33 Use of Ibrutinib for Chronic Lymphocytic Leukemia (CLL) in Routine Clinical Practice: Results from the Belgian Ibrutinib Real-World Data (BiRD) Study

Article: P34 A crépinette sign

Article: P35 In-house developed 15-gene sequencing panel for acute myeloid leukemia and myelodysplasia allows robust detection of genetic defects including FLT3-ITD and CEBPA mutations

Article: P35 PD-1 blockade in a patient with relapsed Hodgkin lymphoma post-allogeneic hematopoietic cell transplant: complete metabolic response without graft-versus-host-disease

Article: P36 Can CLL-IPI at time of diagnosis predict who may never need treatment for B-CLL?

Article: P36 Next generation sequencing in patients with therapy-related myeloid neoplasms

Article: P37 CD123 expression on acute leukemia blasts, hematogones, and monocytes; used as Minimal Residual Disease Marker

Article: P37 Comparison of Multigam® IV (5% vs. 10%) in hematological patients with secondary immunodeficiencies to evaluate infusion time, tolerability and satisfaction. A monocentric observational Belgian study